- CA$452.08m
- CA$441.54m
- CA$13.85m
- 63
- 25
- 47
- 41
2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 13.9 |
Cost of Revenue | |||||
Gross Profit | — | — | — | — | 2.82 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1.34 | 2 | 1.47 | 5.62 | 17.6 |
Operating Profit | -1.34 | -2 | -1.47 | -5.62 | -3.78 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.07 | -2.83 | -1.85 | -6.45 | -5.86 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.82 | -2.7 | -1.38 | -4.26 | -5.84 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.82 | -2.7 | -1.38 | -4.26 | -5.84 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.82 | -2.7 | -1.38 | -4.26 | -5.84 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.059 | -0.053 | -0.019 | -0.047 | -0.06 |
Dividends per Share |